Business Wire

Biotech and Pharma Labs Performing Endpoint PCR Can Reduce Amplification Time to 15 Minutes With New Promega Reagent and Eppendorf Instrument Combination

HAMBURG, Germany & MADISON, Wis.--(BUSINESS WIRE)--Biotech and pharma labs performing endpoint polymerase chain reaction (PCR) can amplify samples in as little as 15 minutes with new Promega GoTaq® ...
GEN

PCR: The Ubiquitous Molecular Biology Workhorse Reasserts its Continued Relevance

In this eBook, sponsored by Thermo Fisher Scientific, we examine the rising role of genetics in medical diagnostics, including polymerase chain reaction (PCR), genomic sequencing, and gene-based micro ...

Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...
GEN

PCR @ 30: From Whence It Sprang

In the summer of 1984, Henry Erlich, Glenn Horn, Randy Saiki, and myself were working on developing a DNA test for sickle cell anemia (SCA) at Cetus Corp. SCA is an autosomal dominant disease caused ...
Morningstar

Global Real-time PCR Systems Market to Reach USD 13.7 Billion by 2035, with Canada Being Top Performing Country at a Decent 8.9% Value CAGR from 2025 to 2035 | Future Market ...

The rising prevalence of infectious diseases, including emerging viral outbreaks, is a major factor fueling market growth. Additionally, increasing investments in precision medicine and personalized ...